Literature DB >> 11291932

Receptors and ligands for autocrine growth pathways are up-regulated when pancreatic cancer cells are adapted to serum-free culture.

L O Murphy1, Y H Abdel-Wahab, Q J Wang, J A Knezetic, J Permnert, J Larsson, A M Hollingsworth, T E Adrian.   

Abstract

Overexpression of autocrine growth factors and their receptors has been reported in many human cancers. The study of autocrine-regulated pathways using in vitro culture systems can be hindered by the presence of fetal bovine serum in culture medium. A human pancreatic cancer cell line (HPAF) was slowly weaned from its dependence on fetal bovine serum and subsequently maintained in serum-free conditions. Growth factor secretion studies showed that production of autocrine growth factors such as transforming growth factor alpha, gastrin-releasing peptide, and insulin-like growth factor I from weaned cells increased three times compared with nonweaned cells (p < 0.01). The epidermal growth factor and gastrin-releasing peptide receptor densities were also increased in weaned cells (2 times and 2.5 times, respectively, p < 0.05). The proliferation of weaned cells cultured continuously in the same medium was significantly greater than of nonweaned cells (p < 0.05). Collectively, these data indicate that weaned pancreatic cancer cells can proliferate in the absence of serum by up-regulating autocrine pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11291932     DOI: 10.1097/00006676-200104000-00011

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  8 in total

1.  Establishment and characterization of SUIT-58 pancreas cancer cell line and its subline S58-SF adapted to serum-free condition derived from metastatic liver tumor.

Authors:  Nobuyasu Takahashi; Fumiyo Aoyama; Jiro Ohuchida; Naoki Sameshima; Yujiro Asada; Akira Sawaguchi
Journal:  Hum Cell       Date:  2015-07-04       Impact factor: 4.174

2.  Alteration in the cytosolic triacylglycerol biosynthetic machinery leads to decreased cell growth and triacylglycerol synthesis in oleaginous yeast.

Authors:  Akanksha Gangar; Sumana Raychaudhuri; Ram Rajasekharan
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

3.  Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system.

Authors:  Oliver Stoeltzing; Wenbiao Liu; Fan Fan; Christine Wagner; Kathrin Stengel; Ray J Somcio; Niels Reinmuth; Alexander A Parikh; Daniel J Hicklin; Lee M Ellis
Journal:  Cancer Lett       Date:  2007-10-22       Impact factor: 8.679

4.  Insulin-like growth factor binding protein-5 influences pancreatic cancer cell growth.

Authors:  Sarah K Johnson; Randy S Haun
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

5.  Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer.

Authors:  Oliver Stoeltzing; Wenbiao Liu; Niels Reinmuth; Fan Fan; Alexander A Parikh; Corazon D Bucana; Douglas B Evans; Gregg L Semenza; Lee M Ellis
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 6.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

Review 7.  Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers.

Authors:  Gökçe Güllü; Sevgi Karabulut; Mustafa Akkiprik
Journal:  Chin J Cancer       Date:  2012-02-07

Review 8.  Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer.

Authors:  Divya Thomas; Prakash Radhakrishnan
Journal:  Cancers (Basel)       Date:  2020-05-13       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.